|
1) Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation. 2003; 107: 2850-6
|
|
|
|
2) Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005; 352: 362-72
|
|
|
|
|
|
3) Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995; 333: 288-93
|
|
|
|
|
|
4) Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107: 2227-32
|
|
|
|
|
|
5) Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44: 1903-10
|
|
|
|
|
|
6) Lekanne Deprez RH, Muurling-Vlietman JJ, Hruda J, et al. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene. J Med Genet. 2006; 43: 829-32
|
|
|
|
|
|
7) Ho CY, Lever HM, DeSanctis R, et al. Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation. 2000; 102: 1950-5
|
|
|
|
|
|
8) Arad M, Penas-Lado M, Monserrat L, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005; 112: 2805-11
|
|
|
|
|
|
9) Kubo T, Gimeno JR, Bahl A, et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol. 2007; 49: 2419-26
|
|
|
|
|
|
10) Niimura H, Patton KK, McKenna WJ, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation. 2002; 105: 446-51
|
|
|
|
|
|
11) Anan R, Niimura H, Takenaka T, et al. Mutations in the genes for sarcomeric proteins in Japanese patients with onset sporadic hypertrophic cardiomyopathy after age 40 years. Am J Cardiol. 2007; 99: 1750-4
|
|
|
|
|
|
12) Harshfield GA, Grim CE, Hwang C, et al. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 1990; 3: 538-43
|
|
|
|
|
|
13) Post WS, Larson MG, Myers RH, et al. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997; 30: 1025-8
|
|
|
|
|
|
14) Morita H, Larson MG, Barr SC, et al. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation. 2006; 113: 2697-705
|
|
|
|
|
|
15) Morita H, Rehm HL, Menesses A, et al. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med. 2008; 358: 1899-908
|
|
|
|
|
|
16) Daw EW, Chen SN, Czernuszewicz G, et al. Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet. 2007; 16: 3463-71
|
|
|
|
|
|
17) Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest. 2005; 115: 518-26
|
|
|
|
|